- Question from JGordon: Are we going to have a vaccine for non-HER2 cancer survivors in the near future? Are we doing Phase II or III clinical trials?
- Answers - Nicholas Robert, M.D. The idea of a vaccine and cancer has always been an exciting one. If we could just vaccinate patients against cancer. Unfortunately, in breast cancer, approaches to date have not been successful. There was a recent large trial in metastatic breast cancer that many groups were involved in, which unfortunately was not successful. This included patients with HER2-negative breast cancer. We are looking at another trial that will include HER2-negative breast cancer in the metastatic setting, and if this trial is positive, we could consider a similar approach in early breast cancer.
On Wednesday, June 24, 2009, our Ask-the-Expert Online Conference was called Updates from the ASCO Annual Meeting. Nick Robert, M.D. and Beth Baughman Dupree, M.D., F.A.C.S. answered your questions about the newest findings on risk, screening, treatment, and more.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.